UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

Pain (Amsterdam), 1999-02, Vol.79 (2), p.303-312

1999

Volltextzugriff (PDF)

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

Cancer chemotherapy and pharmacology, 2000, Vol.46 (1), p.19-26

2000

Volltextzugriff (PDF)

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation

Bone marrow transplantation (Basingstoke), 2000-07, Vol.26 (2), p.203-210

2000

Volltextzugriff (PDF)

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

British journal of cancer, 2001-06, Vol.84 (12), p.1591-1598

2001

Volltextzugriff (PDF)

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2631-2637

1996

Volltextzugriff (PDF)

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2882-2893

1997

Volltextzugriff (PDF)

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer

British journal of cancer, 2002-07, Vol.87 (3), p.281-288

2002

Volltextzugriff (PDF)

Phase II trial of carboplatin and infusional cyclosporine with alpha‐interferon in recurrent ovarian cancer: a California Cancer Consortium Trial

International journal of gynecological cancer, 2007-03, Vol.17 (2), p.373-378

2007

Volltextzugriff (PDF)

A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies

European journal of surgical oncology, 2004-08, Vol.30 (6), p.650-657

2004

Volltextzugriff (PDF)

Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer

Blood, 1997-03, Vol.89 (5), p.1521-1528

1997

Volltextzugriff (PDF)

High‐dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high‐risk primary breast cancer

Cancer, 1994-01, Vol.73 (1), p.125-134

1994

Volltextzugriff (PDF)

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

Bone marrow transplantation (Basingstoke), 2001-11, Vol.28 (9), p.859-863

2001

Volltextzugriff (PDF)

Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial

Journal of clinical oncology, 1995-05, Vol.13 (5), p.1231-1237

1995

Volltextzugriff (PDF)

Phase I study of mitomycin C and menadione in advanced solid tumors

Cancer chemotherapy and pharmacology, 1995, Vol.36 (4), p.293-298

1995

Volltextzugriff (PDF)

Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 1997-01, Vol.39 (3), p.254-258

1997

Volltextzugriff (PDF)

High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support

Clinical cancer research, 1997-12, Vol.3 (12), p.2337-2345

1997

Volltextzugriff (PDF)

High‐dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high‐risk primary breast cancer

Cancer, 1994-03, Vol.73 (6), p.1678-1685

1994

Volltextzugriff (PDF)

NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network

Oncology (Williston Park, N.Y.), 1996-11, Vol.10 (11 Suppl), p.179

1996

Volltextzugriff (PDF)

Effective initial therapy of advanced breast cancer with fluorouracil and high-dose, continuous infusion calcium leucovorin

Journal of clinical oncology, 1992-08, Vol.10 (8), p.1278-1283

1992

Volltextzugriff (PDF)

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A

Cancer chemotherapy and pharmacology, 2000-11, Vol.46 (5), p.403-410

2000

Volltextzugriff (PDF)

Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer

Cancer research (Baltimore), 1992-05, Vol.52 (9), p.2408-2412

1992

Volltextzugriff (PDF)

Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma

Journal of clinical oncology, 1992-10, Vol.10 (10), p.1574-1578

1992

Volltextzugriff (PDF)

Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer

American journal of clinical oncology, 1994-04, Vol.17 (2), p.175-180

1994

Volltextzugriff (PDF)

Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea

Cancer chemotherapy and pharmacology, 1994, Vol.35 (2), p.161-164

1994

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

Humans
(61)
Science & Technology
(57)
Life Sciences & Biomedicine
(56)
Female
(53)
Biological And Medical Sciences
(50)
Medical Sciences
(50)
Middle Aged
(48)
Adult
(45)
Oncology
(43)
Pharmacology. Drug Treatments
(39)
Male
(38)
Aged
(36)
Antineoplastic Agents
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Chemotherapy
(31)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(19)
Pharmacology & Pharmacy
(17)
Infusions, Intravenous
(16)
Cisplatin - Administration & Dosage
(14)
Breast Neoplasms - Drug Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation

High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome

Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer

Phase II trial of carboplatin and infusional cyclosporine with alpha‐interferon in recurrent ovarian cancer: a California Cancer Consortium Trial

A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies

Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer

High‐dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high‐risk primary breast cancer

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

Effect of low-dose prophylactic dopamine on high-dose cisplatin-induced electrolyte wasting, ototoxicity, and epidermal growth factor excretion: a randomized, placebo-controlled, double-blind trial

Phase I study of mitomycin C and menadione in advanced solid tumors

Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumors

High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support

High‐dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high‐risk primary breast cancer

NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network

Effective initial therapy of advanced breast cancer with fluorouracil and high-dose, continuous infusion calcium leucovorin

A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A

Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer

Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma

Recombinant Human Thrombopoietin in Combination With Granulocyte Colony-Stimulating Factor Enhances Mobilization of Peripheral Blood Progenitor Cells, Increases Peripheral Blood Platelet Concentration, and Accelerates Hematopoietic Recovery Following High-Dose Chemotherapy

Phase II trial of 5-fluorouracil and high-dose folinic acid as first- or second-line therapy for advanced breast cancer

Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea

Suchergebnisse filtern